{"id":727,"date":"2016-08-09T08:43:38","date_gmt":"2016-08-09T08:43:38","guid":{"rendered":"http:\/\/www.cs.ubbcluj.ro\/~fca\/?page_id=727"},"modified":"2016-08-10T08:23:42","modified_gmt":"2016-08-10T08:23:42","slug":"softcom-2016","status":"publish","type":"page","link":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/application-of-fca-in-medicine\/softcom-2016\/","title":{"rendered":"SOFTCOM 2016"},"content":{"rendered":"\n\n\n\n\n\n\n\n
[(non-comedo);(PCT);(Pc T,Pc N)]
\n[(comedo);(surgery,PCT);(Bio)]
\n[(cribriform,comedo,alveo,non-comedo,paget);(PCT);
\n(Bio)]
\n[(comedo,alveo,cli);(surgery);(Bio)]
\n[(comedo,non-comedo,coloidal,cribriform); (PCTneoadj);
\n(Pc T)]
\n[(comedo,cribriform);(PCT);(Pc T,Bio)]<\/td>\n<\/tr>\n
Tricontext 1: Types of carcinoma (objects), First applied treatment (attributes), Confirmation Mode (conditions)<\/th>\n<\/tr>\n
[(Pc T);(PCT);(cons,rad,nosurgery)]
\n[(Pc T,Bio);(surgery,PCT);(cons)]
\n[(Bio);(surgery,PCT);(rad)]
\n[(Bio);(surgery,PCT);(cons, rad)]
\n[(Pc T,Bio);(PCT);(cons, rad)]
\n[(Pc T);(PCT,Meta);(rad)]
\n[(Pc T,Bio,Pc N);(PCT);(rad)]<\/td>\n<\/tr>\n
Tricontext 2: Confirmation Mode (objects), First applied treatment (attributes), Comitee indication (conditions)<\/th>\n<\/tr>\n
[(liver);(A,DTX,T);(vomiting,nausea)]
\n[(bone);(EC,CMF);(vomiting,alopecia,neutropenia,nausea)]
\n[(pleurisy);(AC,TXT);(vomiting, alopecia, nausea)]
\n[(lung);(AC); (edema, appendages, neutropenia, nausea)]<\/td>\n<\/tr>\n
Tricontext 3: Location of Metastasis(objects), Treatment(attributes), Drug Adverse Reactions(conditions)<\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\"disease\"<\/td>\n<\/tr>\n
Fig. 1. Carcinoma map<\/th>\n<\/tr>\n
\"partialtopo\"<\/td>\n<\/tr>\n
Fig. 2. Cancer tumor topography. Partial view.<\/th>\n<\/tr>\n
\"Figure1\"<\/td>\n<\/tr>\n
Fig. 3. DTX adverse reactions: complete distribution view. The Nauseanode is selected, highlighting all combinations of adverse effects that includenausea. The results are in count format, showing the number of patients thathave suffered all the adverse effects determining a certain node.<\/th>\n<\/tr>\n
\"2016_carcinoma_localizareresuta\"<\/td>\n<\/tr>\n
Fig. 4. Carcinoma map vs metastasis location in a circular layout<\/th>\n<\/tr>\n
\"2016_tipPCTmetastatica_localizareresuta\"<\/td>\n<\/tr>\n
Fig. 5. Metastasis location vs recommended treatment in a circular layout<\/th>\n<\/tr>\n
\"2016_simptom_localizareresuta\"<\/td>\n<\/tr>\n
Fig. 6. Symptoms list vs metastasis location in a circular layout<\/th>\n<\/tr>\n
\"2016_basis_sex\"<\/td>\n<\/tr>\n
2016_basis_sex<\/th>\n<\/tr>\n
\"2016_tumor_sequence_sex\"<\/td>\n<\/tr>\n
2016_tumor_sequence_sex<\/th>\n<\/tr>\n
\"age\"<\/td>\n<\/tr>\n
age<\/th>\n<\/tr>\n
\"scala\"<\/td>\n<\/tr>\n
scala<\/th>\n<\/tr>\n
\"survival\"<\/td>\n<\/tr>\n
survival<\/th>\n<\/tr>\n
\"topography\"<\/td>\n<\/tr>\n
topography<\/th>\n<\/tr>\n
\"2016_vital_sex\"<\/td>\n<\/tr>\n
2016_vital_sex<\/th>\n<\/tr>\n
\"2016_tratamente_sex\"<\/td>\n<\/tr>\n
2016_tratamente_sex<\/th>\n<\/tr>\n
\"2016_behavior_sex\"<\/td>\n<\/tr>\n
2016_behavior_sex<\/th>\n<\/tr>\n
\"2016_condensedTNM_sex\"<\/td>\n<\/tr>\n
2016_condensedTNM_sex<\/th>\n<\/tr>\n
\"2016_grade_sex\"<\/td>\n<\/tr>\n
2016_grade_sex<\/th>\n<\/tr>\n
\"2016_laterality_sex\"<\/td>\n<\/tr>\n
2016_laterality_sex<\/th>\n<\/tr>\n
\"2016_simptom_localizareresuta\"<\/td>\n<\/tr>\n
Fig. 6. Symptoms list vs metastasis location in a circular layout<\/th>\n<\/tr>\n
\"2016_TNM_sex\"<\/td>\n<\/tr>\n
2016_TNM_sex<\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

[(non-comedo);(PCT);(Pc T,Pc N)] [(comedo);(surgery,PCT);(Bio)] [(cribriform,comedo,alveo,non-comedo,paget);(PCT); (Bio)] [(comedo,alveo,cli);(surgery);(Bio)] [(comedo,non-comedo,coloidal,cribriform); (PCTneoadj); (Pc T)] [(comedo,cribriform);(PCT);(Pc T,Bio)] Tricontext 1: Types of carcinoma (objects), First applied treatment (attributes), Confirmation Mode (conditions) [(Pc T);(PCT);(cons,rad,nosurgery)] [(Pc T,Bio);(surgery,PCT);(cons)] [(Bio);(surgery,PCT);(rad)] [(Bio);(surgery,PCT);(cons, rad)] [(Pc T,Bio);(PCT);(cons, rad)] [(Pc T);(PCT,Meta);(rad)] [(Pc T,Bio,Pc N);(PCT);(rad)] Tricontext 2: Confirmation Mode (objects), First applied treatment (attributes), Comitee indication (conditions) [(liver);(A,DTX,T);(vomiting,nausea)] [(bone);(EC,CMF);(vomiting,alopecia,neutropenia,nausea)] … <\/p>\n

Continue reading “SOFTCOM 2016”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":302,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"full-width-page.php","meta":{"footnotes":""},"class_list":["post-727","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/pages\/727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/comments?post=727"}],"version-history":[{"count":14,"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/pages\/727\/revisions"}],"predecessor-version":[{"id":761,"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/pages\/727\/revisions\/761"}],"up":[{"embeddable":true,"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/pages\/302"}],"wp:attachment":[{"href":"https:\/\/www.cs.ubbcluj.ro\/research\/fca\/wp-json\/wp\/v2\/media?parent=727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}